Table 1 PinX1 staining and clinicopathological characteristics of 405 breast cancer patients
Variables | PinX1 staining | |||
|---|---|---|---|---|
Low (%) | High (%) | Total | P * | |
Age | ||||
≤50 years | 99 (52.7) | 89 (47.3) | 188 | 0.906 |
>50 years | 113 (52.1) | 104 (47.9) | 217 | |
Tumor size | ||||
T1 (<2 cm) | 47 (61.8) | 29 (38.2) | 76 | 0.090 |
T2 (2-5 cm) | 148 (51.2) | 141 (48.8) | 289 | |
T3 (>5 cm) | 11 (39.3) | 17 (60.7) | 28 | |
Lymph node metastasis | ||||
Negative | 83 (43.5) | 108 (56.5) | 191 | 0.002 |
Positive | 110 (59.5) | 75 (40.5) | 185 | |
Histology grade | ||||
I | 11 (30.6) | 25 (69.4) | 36 | 0.001 |
II | 103 (50.5) | 101 (49.5) | 204 | |
III | 50 (68.5) | 23 (31.5) | 73 | |
ER status | ||||
Negative | 40 (54.8) | 33 (45.2) | 73 | 0.359 |
Positive | 63 (48.1) | 68 (51.9) | 131 | |
PR status | ||||
Negative | 48 (54.5) | 40 (45.5) | 88 | 0.313 |
Positive | 55 (47.4) | 61 (52.6) | 116 | |
HER2 status | ||||
Negative | 14 (66.7) | 7 (33.3) | 21 | 0.206 |
Positive | 79 (52.0) | 73 (48.0) | 152 | |
p53 status | ||||
Negative | 41 (50.0) | 41 (50.0) | 82 | 0.347 |
Positive | 52 (57.1) | 39 (42.9) | 91 | |